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Abstract
A protein fraction purified from bovinebrain myelin, previously called
arretin because of its ability to inhibit neurite outgrowth, has been
identified as consisting predominantly of oligodendrocyte-myelin
glycoprotein (OMgp). We show that it is a potent inhibitor of neurite
outgrowth from rat cerebellar granule and hippocampal cells; from
dorsal root ganglion explants in which growth cone collapse was
observed; from rat retinal ganglion neurons; and from NG108 and
PC12 cells. OMgp purified by a different procedure from both mouse
and human myelin behaves identically in all bioassays tested.
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The failure of injured axons to regenerate long distances in the adult
mammalian CNS leads to permanent paralysis and other functional
deficits such as those seen after spinal cord injuries. Although axons do
not regenerate through adult CNS tissue, they retain the ability to regrow
for long distances if provided with an appropriate cellular environment,
for example a peripheral nerve graft (David and Aguayo 1981). Work by
Schwab and colleagues led to the discovery that this failure of axons to
regenerate was likely to be caused, in part, by the influence of axon
growth inhibitory activity associated with myelin (Caroni and Schwab
1988; Schwab and Bartholdi 1996; Horner and Gage 2000). Nogo-A
(Chen et al. 2000; Fournier et al. 2001; GrandPre et al. 2002), myelin-
associated glycoprotein (MAG) (McKerracher et al. 1994; Mukhopad-
hyay et al. 1994), and several proteoglycans (Niederost et al. 1999) have
been identified as myelin associated molecules that impede axonal
regeneration in the adult mammalian CNS.
In our studies onMAGas a neurite growth inhibitor (McKerracheret al.
1994), we observed non-MAG containing chromatographic fractions
eluting in 2–3 M NaCl solution from an anion exchange column that
contained very low concentrations of protein but were highly active in
bioassays. Further chromatographic purification on a peanut agglutinin
lectin, as an affinity support, resulted in column fractions having very
potent neurite growth inhibition. We called this potent activity arretin.
However, these biologically active fractions still contained several
electrophoretically separable components detected on silver-stained gels.
We now show that: (i) the dominant protein of arretin is oligodendrocyte-
myelin glycoprotein (OMgp); (ii) authentic OMgp isolated by a different
procedure and recombinant OMgp both inhibit neurite outgrowth. Aspects
of this work were presented at the Twenty Third International Symposium
on Spinal Cord Trauma, Montreal, 2001b.
Materials and methods
Purification of arretin and OMgp
Myelin was prepared from bovine brain, extracted with octylgluco-
side salt, and chromatographed on diethylaminoethyl (DEAE)-Sepharose
(Pharmacia) as previously described (McKerracher et al. 1994). Column
fractions eluting in 1.5–2 M NaCl solution were pooled, diluted three-
fold, and loaded on a peanut agglutinin (PNA)-agarose column.
Following a wash with 2 M NaCl in 20 mM triethanolamine (pH 7.5)
and a cocktail of protease inhibitors arretin was eluted with 0.5 M
D-galactose in the wash buffer. The eluate was dialysed against H2O and
lyophilized. The protein was re-dissolved in a minimum volume of H2O.
OMgp from either mouse or human brain was purified following the
method described by Mikol and Stefansson (1988). The anti-OMgp used
for western blots and for immunodepletion experiments was raised in
rabbits and affinity purified (Dr Mikol, University of Michigan, MI,
USA). All chemicals were purchased from Sigma-Aldrich Canada Ltd.
Immunodepletion of OMgp
In order to establish that the bioactivity in our sample of OMgp was not
caused by minor contaminants, we subjected the sample to four rounds
of immunodepletion (McKerracher et al. 1994). Briefly, the mouse
OMgp sample in 50 mM Tris buffer, pH 7, was incubated with the
affinity purified rabbit anti-OMgp overnight at 4C with rotation.
Protein A beads were added for 3 h with rotation, centrifuged (50 000 g,
10 min) and the supernatant was subjected to three repeat treatments as
described above. The final depleted samples, as well as the protein A
beads containing the immunosorbed OMgp, were separated by sodium
dodecyl sulfate ) polyacrylamide gel electrophoresis (SDS–PAGE) for
silver staining and western blotting, and bioassays were performed as
described below.
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Neurite outgrowth assays and growth cone collapse
Assays for neurite outgrowth have been described (Xiao et al. 1996;
Huang et al. 1999). Briefly, inhibitors were applied as a spot to
nitrocellulose and poly-L-lysine coated wells and incubated overnight at
37C in a humidified atmosphere.Wellswere rinsed, andNG108-15, PC12
or primary cells were plated in chemically defined media. Cells were
allowed to grow for 48 h, fixed with 4% paraformaldehyde in phosphate-
buffered saline (PBS), stained with Coomassie blue, washed and dried.
Cerebellar and hippocampal neurons, rat dorsal root ganglion cells, and rat
retinal ganglion neurons were cultured, and neurites quantified as
described (Huang et al. 1999). Growth cone collapse assays with image
analysis and quantification, are being performed in the laboratory of
Dr Lisa McKerracher (Université de Montréal, Montreal, QC, Canada).
Expression of recombinant OMgp
The full length cDNA encoding rat OMgp was cloned by RT-PCR and
subcloned into the pCMS-EGFP vector for expression in eukaryotic
cells. Transfected cells were collected and lysed in 50 mM Tris pH 8, 1%
octylglucoside and protease inhibitors at 4C for 1 h, then sonicated for
30 s and centrifuged at 15 000 g for 30 min at 4C. Lysates were
collected, diluted 3-fold, and PNA-agarose beads were added and
incubated overnight at 4C with mixing. The beads were washed, and the
OMgp was eluted as in the arretin purification.
Results
We previously described preliminary attempts to characterize a low
abundance but highly active growth inhibitor that eluted with 1.5–2.0 M
NaCl from a DEAE ion exchange column (Fig. 1a; McKerracher et al.
1994; Xiao et al. 1997). Further chromatography on a lectin support
(PNA) yielded an inhibitory fraction (1 lg protein, starting from
100 mg of bovine brain myelin protein). The silver-stained electro-
phoretic profile is shown in Fig. 1(b). Mass spectrophotometric analysis
of each silver-stained band revealed that either OMgp (110 kDa) or its
degradation fragments collectively account for the major protein, aside
from the band of PNA that spuriously eluted from the column. Several
other minor components are evident, including tenascin-R (J1-160/180),
and versican 3. Western blots (not shown) with anti-OMgp confirmed
the identity of OMgp. An authentic sample of mouse OMgp, purified
independently by a different procedure (Mikol and Stefansson 1988)
proved to have minor contaminants that we also identified by mass
spectrometry (Fig. 1c); none of these are known to have growth
inhibitory properties in our assays.
Figure 2 demonstrates the neurite growth inhibitory properties in a
bioassay of arretin at 1–2 nM, using NG108 cells (Fig. 2a), rat dorsal
root ganglia (Fig. 2b), cerebellar granule cells and hippocampal neurons
(Fig. 2c). Growth cone collapse in response to arretin was also observed
in early experiments, but quantification is not yet complete. Figure 3(a)
shows the inhibition of neurite outgrowth by mouse OMgp (1–2 nM) in

























































Fig. 1 (a) Scheme summarizing the purification of arretin. (b) SDS–PAGE
profile of arretin. Proteins were separated on a 12% polyacrylamide gel,
and stained with silver. All visible bands were subjected to mass spectro-
metric analysis to identify proteins. CNP, 2¢,3¢-cyclic nucleotide 3¢ phos-
phodiesterase; PNA, peanut agglutinin. (c) SDS–PAGE profile of purified
OMgp. OMgp was purified as previously described (Mikol and Stefansson































































































Fig. 2 Inhibition of neurite outgrowth by arretin. (a) Arretin (1–2 nM) is
strongly inhibitory for neurite extension from NG108 cells. (b) Neurite out-
growth from mouse dorsal root ganglion explants (P6–7) is inhibited by
arretin (1–2 nM). The control was the laminin substrate alone. (c) In both
cerebellar granule cells and hippocampal neurons, neurite outgrowth is
inhibited (in a dose responsive manner for hippocampal neurons). This
inhibitory effect is greatly reduced when the arretin is partially denatured
(DN) by heating to 80C for 15 min.
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NG108 cells. When recombinant OMgp was expressed in 293T cells, a
detergent extract of these cells demonstrated inhibition of neurite
outgrowth from PC12 cells (Fig. 3b); a similar inhibitory response was
observed with NG108 cells (not shown). Immunodepletion of the mouse
OMgp sample with the affinity purified anti-OMgp (Fig. 3c) abolished
the inhibitory response; the bioassay results looked exactly like the
control NG108 cells seen in Fig. 3(a). Thus the minor contaminants
found in purified samples do not contribute significantly to the inhibitory
response. Human OMgp, prepared by the same procedure as that for
mouse, elicited a vigorous inhibitory response in our neurite outgrowth
assay with rat retinal ganglion cells (Fig. 4).
Discussion
Numerous observations suggest that the CNS myelin sheath possesses
multiple inhibitors of axon regeneration. Although Nogo (Chen et al.
2000; GrandPre et al. 2000), MAG (McKerracher et al. 1994; Mukho-
padhyay et al. 1994), and several chondroitin sulfate proteoglycans
(Niederost et al. 1999) have been most prominently studied, we now
conclude that a potent myelin-associated inhibitory activity, previously
reported as arretin (Xiao et al. 1997) is OMgp. Authentic samples of
OMgp purified from mouse or human brain by a different procedure
evinced the same inhibitory properties as arretin. This glycoprotein of
110–120 kDa (440 amino acids) is glycosylphosphatidylinositol-linked
to the cell membrane in myelinating oligodendrocytes, and is localized to
the glial–axonal interface of myelinated axons (Mikol et al. 1990a,b,
1993; Habib et al. 1998). The protein is a relatively minor component of
CNS myelin, the temporospatial appearance of which during develop-
ment parallels the pattern of myelination (Mikol and Stefansson 1988).
Mouse and human OMgp are structurally very similar; the protein has a
series of tandem leucine-rich repeats, like those in a variety of adhesion
molecules and receptors, including the Nogo receptor; this domain











Fig. 3 Inhibition of neurite growth by mouse and recombinant OMgp. (a)
NG108 cells grown in the presence of purified mouse OMgp (1–2 nM)
manifest strong inhibition of neurite growth. (b) Neurite outgrowth from
PC12 cells is inhibited by response to recombinant OMgp, in the form of an
octylglucoside extract of transfected 293T cells that has been eluted from a
PNA column. (c) Immunodepletion of purified mouse OMgp. Lane 1, the
major OMgp band detected either by silver staining or by western blotting.
Lane 2, absence of OMgp after four cycles of immunodepletion. Lane 3,
OMgp electrophoretically recovered from the protein A beads following
immunodepletion.
PLL
Rat retinal ganglion cells
Mouse OMgp
Human OMgp
Fig. 4 Inhibition of neurite outgrowth from rat retinal ganglion neurons by
mouse and human OMgp. Mouse OMgp was bioassayed at two concen-
trations (2.5 and 10 U), representing 1–2 nm, and 2–8 nm, respectively).
Human OMgp was estimated to be between 2 and 10 nm. PLL, poly-L-
lysine control.
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that the observed ability to inhibit neurite outgrowth and, by extension,
axonal regeneration is not the only function of OMgp, and a normal
physiological role remains to be determined.
While this work was being prepared for publication, a Nature advance
online publication reported that OMgp binds to the Nogo receptor with
high affinity, and that this induces growth cone collapse and inhibition of
neurite outgrowth (Wang et al. 2002). Our own observations on the
potency of OMgp, and those reported by Wang et al. (2002) strongly
support our view that this protein should be considered as a major
obstacle to nerve regeneration. (Additionally, while our manuscript was
in review, Liu et al. 2002 and Domeniconi et al. 2002 reported that
MAG is also a functional ligand of the Nogo receptor).
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